Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1<i>H</i>)-One Scaffold

Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1<i>H</i>)-One Scaffold

A growing body of evidence underlines the crucial role of GPR55 in physiological and pathological conditions. In fact, GPR55 has recently emerged as a therapeutic target for several diseases, including cancer and neurodegenerative and metabolic disorders. Several lines of evidence highlight GPR55′s...

Full description

Bibliographic Details
Main Authors: Costanza Ceni, Michael J. Benko, Kawthar A. Mohamed, Giulio Poli, Miriana Di Stefano, Tiziano Tuccinardi, Maria Digiacomo, Massimo Valoti, Robert B. Laprairie, Marco Macchia, Simone Bertini
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pharmaceuticals
Subjects:
GPR55
GPR55 agonist
GPR55 modulator
p-ERK activation assay
quinolin-2-one
benzylquinolin-2-one
Online Access:https://www.mdpi.com/1424-8247/15/7/768

Internet

https://www.mdpi.com/1424-8247/15/7/768

Similar Items